794533-54-3 Usage
Uses
Used in Pharmaceutical Industry:
3-Ethynylpiperidine is used as a building block for the synthesis of various drugs and pharmaceuticals, contributing to the development of new medications due to its unique chemical structure and properties.
Used in Research and Development:
In the realm of research and development, 3-ethynylpiperidine is utilized for exploring its potential biological activity and pharmacological properties, aiding in the discovery and innovation of novel therapeutic agents.
Used in Neurological Disorders Treatment:
3-Ethynylpiperidine has been studied for its potential application in the treatment of neurological disorders, indicating its possible role in managing or alleviating symptoms associated with such conditions.
Used in Chemical Biology Research:
As a tool in chemical biology research, 3-ethynylpiperidine facilitates investigations into the interactions between biological systems and small molecules, furthering our understanding of biological processes and the development of targeted therapies.
It is crucial to handle 3-ethynylpiperidine with care, considering the health hazards and environmental risks it may pose if not properly managed and controlled.
Check Digit Verification of cas no
The CAS Registry Mumber 794533-54-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,4,5,3 and 3 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 794533-54:
(8*7)+(7*9)+(6*4)+(5*5)+(4*3)+(3*3)+(2*5)+(1*4)=203
203 % 10 = 3
So 794533-54-3 is a valid CAS Registry Number.
794533-54-3Relevant academic research and scientific papers
PYRROLO[2,3-B]PYRIDINE CDK9 KINASE INHIBITORS
-
Page/Page column 357; 358, (2014/09/29)
Disclosed are compounds of Formula (IIa), wherein R1, R2, R3A, R3B, R3C, R3D, R3E, and R4 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds may be used as agents in the treatment of diseases, including cancer. Also provided are pharmaceutical compositions comprising one or more compounds of Formula (IIa)
